The Pennine Acute Hospitals
NHS Trust Formulary
 
back
9 Nutrition and blood
09-01-01-02 Parenteral iron

IV iron dose should be calculated according to body weight and iron deficit and administered in strict accordance with the posology and method of administration described in the product information for each individual product (note that advice varies between products) Caution is needed with every dose of intravenous iron that is given, even if previous administrations have been well tolerated

IV iron products should only be administered when staff trained to evaluate and manage anaphylactic or anaphylactoid reactions—as well as resuscitation facilities—are immediately available

Patients should be closely monitored for signs of hypersensitivity during and for at least 30 minutes after every administration of an IV iron product. In the event of a hypersensitivity reaction, treatment should be stopped immediately and appropriate management initiated. Report any adverse effects via the Yellow Card Scheme (www.mhra.gov.uk/yellowcard)


Iron Isomaltoside Monofer®
First Choice
Injection

 
Link  PAT Guideline: Blood management of medical patients
Link  PAT Guideline: Blood management prior to surgery
 

Red View adult BNF  View SPC online  View childrens BNF
Ferric Carboxymaltose Ferinject®
Second Choice
Injection

Red View adult BNF  View SPC online  View childrens BNF
Iron Dextran CosmoFer®
Formulary
Injection


Red View adult BNF  View SPC online  View childrens BNF
Iron Sucrose Venofer®
Formulary
Injection

Red View adult BNF  View SPC online  View childrens BNF